Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation-Reference-Cited by-同舟云学术

Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation

Published:2019-10-28 Issue:1 Volume:10 Page:282-295
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Nguyen Thi-Thao-Linh^ORCID,Duong Van-An^ORCID,Maeng Han-Joo,Chi Sang-Cheol^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1007/s13346-019-00687-2.pdf

Reference60 articles.

1. Roila F, Del Favero A. Ondansetron Clinical Pharmacokinetics. Clin Pharmacokinet. 1995;29(2):95–109. https://doi.org/10.2165/00003088-199529020-00004 .

2. Christofaki M, Papaioannou A. Ondansetron: a review of pharmacokinetics and clinical experience in postoperative nausea and vomiting. Expert Opin Drug Metab Toxicol. 2014;10(3):437–44.

3. Navari RM, Aapro M. Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting. N Engl J Med. 2016;374(14):1356–67. https://doi.org/10.1056/NEJMra1515442 .

4. Deeks ED. Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting. Drugs. 2016;76(18):1779–86. https://doi.org/10.1007/s40265-016-0664-2 .

5. Denge MS, Walde SR, Abhay MI. Development and characterization of transdermal patches of Ondansetron hydrochloride. Int J Pharm Pharm Sci. 2012;4(5):293–8.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and Inflammation;BioNanoScience;2024-04-01

2. Recent advances in lipid-based long-acting injectable depot formulations;Advanced Drug Delivery Reviews;2023-08

3. Bioanalytical method validation, biopharmaceutical and pharmacokinetic evaluation of GSK-650394, a serum- and glucocorticoid-regulated kinase 1 inhibitor;Arabian Journal of Chemistry;2023-02

4. Lipid based intramuscular long-acting injectables: Current state of the art;European Journal of Pharmaceutical Sciences;2022-11

5. Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug;Journal of Drug Delivery Science and Technology;2022-08